Wellington Management Group LLP Boosts Stock Position in LivaNova PLC $LIVN

Key Points

• Wellington Management Group LLP significantly increased its stake in LivaNova PLC by 146.1% during Q1 2023, now holding 472,843 shares valued at approximately $18.57 million.
• Multiple analysts have upgraded LivaNova's stock rating, with price targets ranging from $58 to $64, reflecting a positive outlook with an average target of $59.71.
• LivaNova reported earnings of $1.05 per share in Q2 2023, exceeding expectations and marking a 10.6% revenue increase compared to the previous year.

Wellington Management Group LLP increased its position in LivaNova PLC (NASDAQ:LIVN - Free Report) by 146.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 472,843 shares of the company's stock after buying an additional 280,718 shares during the quarter. Wellington Management Group LLP owned 0.87% of LivaNova worth $18,573,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Algert Global LLC lifted its position in LivaNova by 49.3% in the 1st quarter. Algert Global LLC now owns 177,253 shares of the company's stock worth $6,962,000 after buying an additional 58,540 shares during the last quarter. Aberdeen Group plc lifted its position in LivaNova by 19.3% in the first quarter. Aberdeen Group plc now owns 276,710 shares of the company's stock valued at $10,869,000 after purchasing an additional 44,685 shares during the last quarter. Fox Run Management L.L.C. lifted its position in LivaNova by 35.3% in the first quarter. Fox Run Management L.L.C. now owns 26,838 shares of the company's stock valued at $1,054,000 after purchasing an additional 6,995 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its position in LivaNova by 415.4% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,469 shares of the company's stock valued at $58,000 after purchasing an additional 1,184 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its position in LivaNova by 4,581.9% in the first quarter. Russell Investments Group Ltd. now owns 70,322 shares of the company's stock valued at $2,762,000 after purchasing an additional 68,820 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

LIVN has been the subject of several recent research reports. Robert W. Baird boosted their price objective on LivaNova from $55.00 to $61.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Wolfe Research raised LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 target price on the stock in a research note on Tuesday, May 20th. Barclays boosted their target price on LivaNova from $55.00 to $58.00 and gave the company an "equal weight" rating in a research note on Thursday, August 21st. Needham & Company LLC reissued a "buy" rating and set a $64.00 target price on shares of LivaNova in a research note on Tuesday, May 13th. Finally, Wall Street Zen raised LivaNova from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $59.71.

LivaNova Stock Performance

Shares of LivaNova stock traded down $1.04 during trading on Thursday, hitting $55.45. 445,519 shares of the company's stock traded hands, compared to its average volume of 814,218. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.29 and a quick ratio of 1.09. LivaNova PLC has a 1 year low of $32.48 and a 1 year high of $57.35. The stock has a market capitalization of $3.03 billion, a P/E ratio of -14.25 and a beta of 0.92. The business has a 50-day simple moving average of $47.31 and a 200-day simple moving average of $43.29.

LivaNova (NASDAQ:LIVN - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $1.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.21. LivaNova had a positive return on equity of 14.57% and a negative net margin of 16.13%.The company had revenue of $352.50 million for the quarter, compared to the consensus estimate of $332.20 million. During the same quarter in the prior year, the company earned $0.93 earnings per share. LivaNova's revenue was up 10.6% on a year-over-year basis. As a group, analysts forecast that LivaNova PLC will post 2.85 EPS for the current year.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.